M A Hull

Author PubWeight™ 21.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The isolation and preliminary characterization of temperature-sensitive transformation mutants of Moloney sarcoma virus. Virology 1979 1.54
2 Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 2011 1.54
3 Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000 1.42
4 The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 2000 1.28
5 Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 2003 1.15
6 Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Oncogene 2006 1.13
7 Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells. Br J Cancer 2004 1.03
8 Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. Gastroenterology 2001 0.90
9 Lack of interleukin-4 receptor alpha chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice. J Pathol 2008 0.88
10 The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility. Br J Pharmacol 2012 0.88
11 Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse. Ann Rheum Dis 2007 0.86
12 Variable use of endoscopic haemostasis in the management of bleeding peptic ulcers. Postgrad Med J 2002 0.84
13 Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas. Eur J Cancer 2009 0.83
14 Faecal calprotectin levels before and after weight loss in obese and overweight subjects. Int J Obes (Lond) 2012 0.82
15 Percutaneous endoscopic gastrostomy (PEG): change in practice since 1988. Clin Nutr 2002 0.79
16 Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX). Drug Chem Toxicol 1998 0.77
17 Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells. J Pharmacol Exp Ther 2003 0.77
18 Non-steroidal anti-inflammatory drugs inhibit Helicobacter pylori-induced human neutrophil reactive oxygen metabolite production in vitro. Aliment Pharmacol Ther 1999 0.77
19 Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases. Gut 2006 0.76
20 Commentary: the association between low-dose aspirin use and the incidence of colorectal cancer. Aliment Pharmacol Ther 2013 0.75
21 Percutaneous endoscopic gastrostomy feeding. BMJ 1992 0.75
22 Adding heat probe treatment to adrenaline injection for spurting haemorrhage of peptic ulcers. Injection of adrenaline and human thrombin is best option. BMJ 1997 0.75
23 Differences in sensitivity to developmental toxicants as seen in Xenopus and Pimephales embryos. Bull Environ Contam Toxicol 1996 0.75
24 Evaluation of the developmental toxicity of theophylline, dimethyluric acid, and methylxanthine metabolites using Xenopus. Drug Chem Toxicol 1996 0.75
25 Ciguatera toxicity. Am Fam Physician 1987 0.75
26 Evaluation of the developmental toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX. Drug Chem Toxicol 1998 0.75